ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,963 | -27.5% | 1,875 | -0.8% | 0.00% | – |
| Q2 2023 | $4,085 | +4.9% | 1,891 | +2.0% | 0.00% | – |
| Q1 2023 | $3,893 | +4.9% | 1,854 | +9.4% | 0.00% | – |
| Q4 2022 | $3,712 | -38.1% | 1,695 | +0.5% | 0.00% | – |
| Q3 2022 | $6,000 | +50.0% | 1,686 | +0.7% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 1,675 | +1.0% | 0.00% | – |
| Q1 2022 | $9,000 | -25.0% | 1,659 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -20.0% | 1,659 | +4.5% | 0.00% | – |
| Q3 2021 | $15,000 | – | 1,588 | +1537.1% | 0.00% | – |
| Q2 2021 | $0 | – | 97 | +56.5% | 0.00% | – |
| Q1 2021 | $0 | – | 62 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 62 | +12.7% | 0.00% | – |
| Q3 2020 | $0 | – | 55 | +3.8% | 0.00% | – |
| Q2 2020 | $0 | – | 53 | +15.2% | 0.00% | – |
| Q1 2020 | $0 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |